Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

External Oblique Intercostal Plane Block to Ease Pain After Major Upper Abdominal Surgery

Official title: External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery: A Randomized Controlled Trial

Run by Fudan University · NCT07331441 · Data updated 2026-11-12

This study tests whether adding a bilateral External Oblique Intercostal Plane Block helps reduce pain and opioid use after major upper abdominal laparoscopic surgery.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment78 (estimated)
SponsorFudan University
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedNovember 25, 2026
Study endsDecember 1, 2026
Registry record updatedSeptember 1, 2026
Trial IDNCT07331441 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-85 years with ASA I–III undergoing elective major upper abdominal laparoscopic surgery lasting 2 hours or more, able to use IV PCA.

Probably not a fit

Patients with significant hepatic or renal disease, allergies to local anesthetics, pregnancy, coagulation issues, or recent prolonged opioid use may not benefit or be excluded from benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, assessor-blinded trial compares bilateral External Oblique Intercostal Plane Block plus standard multimodal analgesia to standard multimodal analgesia alone in adults undergoing elective major upper abdominal laparoscopic surgery. Participants receive ultrasound-guided EOIB with ropivacaine before incision, while all receive IV PCA, antiemetics, and NSAIDs per ERAS. The primary outcome is total opioid use in the first 24 hours postoperatively. The study is conducted at a single center with allocation concealment and blinded outcome assessment, aiming to establish safety and analgesic efficacy of EOIB in this surgical population.

Why it matters

Potential benefit: If effective, EOIB could reduce postoperative opioid requirements and pain, potentially improving recovery and reducing opioid-related side effects.

How similar studies have gone: Prior small studies suggest regional blocks like EOIB may reduce pain and opioid needs, but evidence in major upper abdominal surgery remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Obtain written informed consent from participants or their legal representatives
* Age between 18 and 85 years
* American Society of Anesthesiologists (ASA) physical status classification I-III
* Scheduled for elective laparoscopic major upper abdominal surgery (e.g., gastric, hepatic, gallbladder, pancreatic surgery)
* Expected surgical duration ≥ 2 hours
* Ability to use the intravenous patient-controlled analgesia (IV PCA) system

Exclusion Criteria:

* Hepatic disease (liver enzyme levels ≥ 2× the upper limit of normal)
* Renal disease (serum creatinine levels ≥ 2× the upper limit of normal)
* Allergy to local anesthetics or known study-related drugs
* Pregnancy or lactation
* Low surgical incision site (not involving the upper abdominal wall innervated by T6-T10 nerves)
* Coagulopathy or current use of anticoagulant medications
* Opioid use for more than 2 weeks in the past 6 months

Where it's running

  • Fudan University Shanghai Cancer Center
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.